tiprankstipranks
Trending News
More News >
Taysha Gene Therapies (TSHA)
NASDAQ:TSHA
US Market

Taysha Gene Therapies (TSHA) Cash flow

Compare
1,227 Followers

Taysha Gene Therapies Cash Flow

TSHA's free cash flow for Q3 2025 was $-24.27M. For the 2025 fiscal year, TSHA's free cash flow was decreased by $-1.21M and operating cash flow was $-24.17M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -81.22M$ -73.02M$ -88.39M$ -117.04M$ -30.73M
Investing Cash Flow
$ -363.00K$ -7.35M$ -24.93M$ -21.55M$ -9.08M
Financing Cash Flow
$ 76.68M$ 136.39M$ 52.10M$ 39.08M$ 291.06M
End Cash Position
$ 141.64M$ 146.54M$ 90.52M$ 151.74M$ 251.25M
Free Cash Flow
$ -81.60M$ -80.39M$ -113.26M$ -138.60M$ -39.81M
Currency in USD

Taysha Gene Therapies Cash Flow